KOPRANPharmaceuticals
Kopran Ltd — PE Ratio & Valuation Analysis
₹108.04
-6.75%
Current P/E38.54xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E23.2x66.5% above avg
⚠️
21.3% Premium to Industry
KOPRAN P/E 38.54x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹7.99 | ₹150 | 18.8x |
| 2024 | ₹10.55 | ₹212 | 20.1x |
| 2023 | ₹5.65 | ₹241 | 42.7x |
| 2022 | ₹13.77 | ₹151 | 11x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Kopran Ltd Valuation
Kopran Ltd (KOPRAN) currently trades at 38.54x earnings. The Pharmaceuticals sector average PE is 31.77x. KOPRAN commands a premium, reflecting high growth expectations. Historically, KOPRAN has traded at an average PE of 23.2x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
7.64%
Dividend Yield
2.13%
More on Kopran Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.